S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › WEED › Research report
← WEED page
XStocksXray
Market X-Ray report · 19 October 2026

Canopy Growth Corp (WEED)

Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026

Key indicators

Last closeCAD 1.020
52-week range0.990 – 3.280
Return, 1 month / 3 months−22.1% / −23.9%
Return, 1 year / 3 years−46.3% / −89.5%
TrendBelow its 200-day average
RSI (14)24
Volatility (1 year)72.8%
Worst drawdown (1 year)-62.3%
Average daily value traded0.96M CAD
Dividend yield–

Market X-Ray price-based

19/ 100 · High confidence · ahead of 10% of stocks on this exchange
Trend12
Momentum10
Stability (higher is calmer)13
Liquidity52
Income–

Five-year price chart navy: price · brown: 200-day average

-10.4442.9396.301502032021-102023-012024-042025-072026-10

About the company

Canopy Growth Corp is a Canadian cannabis company based in Smiths Falls, Ontario. It produces and sells recreational and medical cannabis products, including dried flower, oils, capsules and other derivative items, under consumer brands such as Tweed. Its customers include adult recreational users and medical patients, along with provincial and territorial retailers and distributors that carry its products, and it also supplies cannabis for medical purposes in several international markets.

The shares are listed on the Toronto Exchange in Canada under the code WEED, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Canopy Growth Corp (WEED) trades on the Toronto Exchange in Canada. It last closed at CAD 1.020 on 19 October 2026.

Its price-based Market X-Ray is 19 out of 100 (a weak price profile), ranking 785 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 46.3% and over the last three months it fell 23.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Canopy Growth Corp (WEED)

The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange

Lens and metricValueScoreReading
Trend12 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-28.7%
From 52-week high-61.5%
Momentum10 · WeakLagging most stocks on this exchange.
3-month return-23.9%
6-month return-35.0%
12-month return, skipping the last month-31.1%
Stability (higher is calmer)13 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)72.8%
Worst drawdown, 1 year (smaller is calmer)-62.3%
Liquidity52 · FairModerate trading activity.
Average daily value traded0.96M CAD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−13.6%
1 month−22.1%
3 months−23.9%
6 months−35.0%
1 year−46.3%
3 years−89.5%
5 years–

Signals

50-day / 200-day average1.310 / 1.430
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.052

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish1 bullish · 0 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026